New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12

Author： Masiero L.

Publisher： Springer Publishing Company

ISSN： 0969-6970

Source： Angiogenesis, Vol.1, Iss.1, 1997-01, pp. : 23-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI)

By Luzzi K.J.

Angiogenesis, Vol. 2, Iss. 4, 1998-01 ,pp. : 373-379

Springer Publishing Company

Access to resources Recommend Favorite

Anti-angiogenesis: A new potential strategy to inhibit restenosis

By Fuchs Shmuel Kornowski Ran Leon Martin B Epstein Stephen E

International Journal of Cardiovascular Interventions, Vol. 4, Iss. 1, 2001-03 ,pp. : 3-6

Informa Healthcare

Access to resources Recommend Favorite

Ovary and ovulation. The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate

By Fraser H.M.

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 2054-2060

Oxford University Press

Access to resources Recommend Favorite

Endostatin and angiostatin: the next anti-angiogenesis generation

By Kohn E.C.

Angiogenesis, Vol. 2, Iss. 1, 1998-01 ,pp. : 25-27

Springer Publishing Company

Access to resources Recommend Favorite

Source Control Review in Clinical Trials of Anti-Infective Agents in Complicated Intra-Abdominal Infections

By Solomkin Joseph S. Ristagno Ross L. Das Anita F. Cone John B. Wilson Samuel E. Rotstein Ori D. Murphy Brian S. Severin Kimberley S. Bruss Jon B.

Clinical Infectious Diseases, Vol. 56, Iss. 12, 2013-06 ,pp. : 1765-1773

Oxford University Press

Access to resources Recommend Favorite